TG Therapeutics, Inc. (TGTX) Social Stream



TG Therapeutics, Inc. (TGTX): $4.40

-0.23 (-4.97%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add TGTX to Watchlist
Sign Up

Industry: Biotech


Ranked

of 396

in industry

Tg Therapeutics Inc (TGTX) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering TGTX.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-05 6 $84 $54 $65 $10.08 544.84%
2021-11-10 6 $84 $54 $64.333 $10.08 538.22%
2021-12-13 7 $75 $36 $53.714 $10.08 432.88%
2022-01-24 7 $70 $36 $53 $10.08 425.79%
2022-01-28 7 $68 $36 $52.714 $10.08 422.96%
2022-02-15 6 $68 $36 $50.285 $10.08 398.86%
2022-02-25 6 $68 $35 $48.285 $10.08 379.02%
2022-03-02 7 $68 $35 $45.666 $10.08 353.04%
2022-03-11 7 $68 $35 $44.857 $10.08 345.01%

The Trend in the Analyst Price Target


Over the past 22 months, TGTX's average price target has gone up $6.36.

Over the past 49 weeks, TGTX's average upside potential has been 299.52%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-01-24 7 70 36 53.000 14.46 266.53%
2022-02-23 6 68 35 48.285 9.43 412.04%
2022-02-25 6 68 35 48.285 9.90 387.73%
2022-03-02 7 68 35 46.857 10.33 353.6%
2022-03-02 7 68 35 48.285 10.33 367.42%

TGTX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 7 0 0 0 0 7

The Trend in the Broker Recommendations


Over the past 90 days, TGTX's average broker recommendation rating improved by 0.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • To contextualize these metrics, consider that out of all US stocks, Tg Therapeutics Inc's upside potential (average analyst target price relative to current price) is higher than 1139.78% of them.
  • To contextualize these metrics, consider that out of all US stocks, Tg Therapeutics Inc's variance in analysts' estimates is lower than -824.84% of them.
  • In the context of Pharmaceutical Products stocks, Tg Therapeutics Inc's average analyst price target is greater than 839.46% of them.
  • TGTX has a greater number of analysts covering the stock than 670.17% of Pharmaceutical Products stocks.

Stocks similar to Tg Therapeutics Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are TBPH, TARO, and SUPN.

What is the outlook for TGTX? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4839 seconds.